ATE460945T1 - Genetische adjuvanz-impfstoffe - Google Patents
Genetische adjuvanz-impfstoffeInfo
- Publication number
- ATE460945T1 ATE460945T1 AT07015414T AT07015414T ATE460945T1 AT E460945 T1 ATE460945 T1 AT E460945T1 AT 07015414 T AT07015414 T AT 07015414T AT 07015414 T AT07015414 T AT 07015414T AT E460945 T1 ATE460945 T1 AT E460945T1
- Authority
- AT
- Austria
- Prior art keywords
- adjuvance
- vaccines
- genetic
- inducing
- nucleic acid
- Prior art date
Links
- 230000002068 genetic effect Effects 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99956885A EP1227840B1 (de) | 1999-11-03 | 1999-11-03 | Genetische impstoffe mit adjuvans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE460945T1 true ATE460945T1 (de) | 2010-04-15 |
Family
ID=38763704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07015414T ATE460945T1 (de) | 1999-11-03 | 1999-11-03 | Genetische adjuvanz-impfstoffe |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1913957B1 (de) |
| AT (1) | ATE460945T1 (de) |
| DE (1) | DE69942161D1 (de) |
| DK (1) | DK1913957T3 (de) |
| SI (1) | SI1227840T1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112569348B (zh) * | 2019-09-29 | 2023-02-28 | 中国食品药品检定研究院 | 一种带状疱疹疫苗 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3221683B2 (ja) * | 1994-01-21 | 2001-10-22 | パウダージェクト ヴァクシンズ， インコーポレイテッド | ガス駆動型遺伝子搬入装置 |
| AU6897098A (en) * | 1997-04-14 | 1998-11-11 | University Of Massachusetts Medical Center | Saponin adjuvants in combination with dna vaccination |
| WO1999027961A1 (en) * | 1997-12-02 | 1999-06-10 | Powderject Vaccines, Inc. | Transdermal delivery of particulate vaccine compositions |
| GB9818627D0 (en) * | 1998-08-26 | 1998-10-21 | Glaxo Group Ltd | Improvements in dva vaccination |
| PT1913957E (pt) * | 1999-11-03 | 2010-05-05 | Powderject Vaccines Inc | Vacinas genéticas adjuvantes |
-
1999
- 1999-11-03 DK DK07015414.1T patent/DK1913957T3/da active
- 1999-11-03 SI SI9930997T patent/SI1227840T1/sl unknown
- 1999-11-03 DE DE69942161T patent/DE69942161D1/de not_active Expired - Lifetime
- 1999-11-03 EP EP07015414A patent/EP1913957B1/de not_active Expired - Lifetime
- 1999-11-03 AT AT07015414T patent/ATE460945T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69942161D1 (de) | 2010-04-29 |
| SI1227840T1 (sl) | 2008-02-29 |
| DK1913957T3 (da) | 2010-05-10 |
| EP1913957B1 (de) | 2010-03-17 |
| EP1913957A1 (de) | 2008-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1487485E (pt) | Adjuvantes de imidazoquinolina para vacinas de adn | |
| DK1459766T3 (da) | Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner | |
| DE69929444D1 (de) | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung | |
| ATE406912T1 (de) | Immunisierung gegen chlamydia tracheomatis | |
| DE60217320D1 (de) | Gonokokkenproteine und nukleinsäuren | |
| DK1047784T3 (da) | Neissera meningitidis-antigener | |
| NZ540544A (en) | Nucleic acids and proteins from streptococcus groups A & B | |
| WO2003059381A3 (en) | Immunogenic preparations and vaccines on the basis of mrna | |
| BR0010361A (pt) | Seq ências genÈmicas de neisseria e uso destas | |
| DE60120621D1 (de) | Lawsonia intracellularis Impfstoff | |
| DE60037900D1 (de) | Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen | |
| CY1107845T1 (el) | Γενετικα εμβολια με ανοσοενισχυτικο | |
| WO2004098526A3 (en) | Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein | |
| ATE460945T1 (de) | Genetische adjuvanz-impfstoffe | |
| DE69922212D1 (de) | Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp) | |
| NO20041564L (no) | Infeksios lakse anemi-virus vaksine | |
| SE9903534D0 (sv) | Vaccin | |
| DK1490100T3 (da) | Kombinerede DNA/proteinvaccinepræparater | |
| Paoletti | Recombinant avipox virus | |
| PT1176192E (pt) | Vacina de helicobacter felis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1913957 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |